List of works - Gabor Szeplaki

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

scientific article

Automated ultra-high-density mapping of peri-sinus node premature atrial contractions.

scientific article published on 8 December 2017

Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure

scientific article published on 4 August 2016

Electroanatomical mapping and radiofrequency ablation of tachycardia originating in pulmonary vein in an adult patient ⬇️

scientific article published on August 21, 2011

Evaluation of the Tp-Te Interval, QTc and P-Wave Dispersion in Patients With Coronary Artery Ectasia.

scientific article published on 22 December 2017

First experience with zero-fluoroscopic ablation for supraventricular tachycardias using a novel impedance and magnetic-field-based mapping system.

scientific article published on 23 February 2018

Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy

scientific article published on 01 October 2018

Impact of respiration gating on image integration guided atrial fibrillation ablation

scientific article published on 7 May 2014

Isolation of persistent left superior vena cava during atrial fibrillation ablation

scientific article published on March 2015

Isolation of the superior vena cava to block unidirectional exit conduction from the right-sided pulmonary veins during atrial fibrillation ablation

scientific article published on 08 April 2017

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score

scientific article published on 10 January 2020

Minimal invasive right ventricular and atrial pacemaker lead repositioning as a first alternative is superior in avoiding pocket complications with passive fixation leads.

scientific article

Novel Biomarkers in Cardiac Resynchronization Therapy: Hepatocyte Growth Factor Is an Independent Predictor of Clinical Outcome

scientific article published on 23 March 2018

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.

scientific article published on 22 November 2017

Quantitative assessment of left atrial scar using high-density voltage mapping and a novel automated voltage analysis tool

article published in 2019

Radiofrequency Ablation at Low Irrigation Flow Rates Using a Novel 12‐Hole Gold Open‐Irrigation Catheter ⬇️

scientific article published on July 22, 2013

Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation

scientific article published on 01 May 2019

Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries.

scientific article published on 28 June 2017

Sex differences in rate and rhythm control for atrial fibrillation

scientific article published on 01 May 2019

Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold-tip catheter: REDUCE-TE Pilot study

scientific article published on 25 March 2019

Successful Catheter Ablation of Right Atrial Tachycardia After Bilateral Lung Transplantation

scientific article published on 29 April 2015

Successful ablation of atrioventricular nodal re-entrant tachycardia in a patient with interruption of inferior vena cava and azygos continuation

scientific article

Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy

scientific article published in January 2016

The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden

scientific article published on 13 August 2020

The impact of cardiac resynchronization therapy on routine laboratory parameters.

scientific article published on March 2017

The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy

scientific article published on 12 May 2015

Usefulness of electroanatomical mapping during transseptal endocardial left ventricular lead implantation ⬇️

scientific article published on December 22, 2011

When to go epicardially during ventricular tachycardia ablation? Role of surface electrocardiogram

scientific article published on 20 December 2013

[Assessment of the extent of myocardial necrosis following radiofrequency catheter ablation of different supraventricular arrhythmias]

scientific article published on 01 April 2019

List of works by Gabor Szeplaki

Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

Automated ultra-high-density mapping of peri-sinus node premature atrial contractions.

Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure

Electroanatomical mapping and radiofrequency ablation of tachycardia originating in pulmonary vein in an adult patient ⬇️

Evaluation of the Tp-Te Interval, QTc and P-Wave Dispersion in Patients With Coronary Artery Ectasia.

First experience with zero-fluoroscopic ablation for supraventricular tachycardias using a novel impedance and magnetic-field-based mapping system.

Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy

Impact of respiration gating on image integration guided atrial fibrillation ablation

Isolation of persistent left superior vena cava during atrial fibrillation ablation

Isolation of the superior vena cava to block unidirectional exit conduction from the right-sided pulmonary veins during atrial fibrillation ablation

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score

Minimal invasive right ventricular and atrial pacemaker lead repositioning as a first alternative is superior in avoiding pocket complications with passive fixation leads.

Novel Biomarkers in Cardiac Resynchronization Therapy: Hepatocyte Growth Factor Is an Independent Predictor of Clinical Outcome

Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.

Quantitative assessment of left atrial scar using high-density voltage mapping and a novel automated voltage analysis tool

Radiofrequency Ablation at Low Irrigation Flow Rates Using a Novel 12‐Hole Gold Open‐Irrigation Catheter ⬇️

Repeat procedure is a new independent predictor of complications of atrial fibrillation ablation

Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries.

Sex differences in rate and rhythm control for atrial fibrillation

Silent cerebral lesions and cognitive function after pulmonary vein isolation with an irrigated gold-tip catheter: REDUCE-TE Pilot study

Successful Catheter Ablation of Right Atrial Tachycardia After Bilateral Lung Transplantation

Successful ablation of atrioventricular nodal re-entrant tachycardia in a patient with interruption of inferior vena cava and azygos continuation

Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy

The Value of Voltage Histogram Analysis Derived Right Atrial Scar Burden in the Prediction of Left Atrial Scar Burden

The impact of cardiac resynchronization therapy on routine laboratory parameters.

The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy

Usefulness of electroanatomical mapping during transseptal endocardial left ventricular lead implantation ⬇️

When to go epicardially during ventricular tachycardia ablation? Role of surface electrocardiogram

[Assessment of the extent of myocardial necrosis following radiofrequency catheter ablation of different supraventricular arrhythmias]

[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis]